Since the first description of a coronavirus-related pneumonia outbreak in December 2019,
the virus SARS-CoV-2 that causes the infection/disease (COVID-19) has evolved into a …

Various comorbidities represent risk factors for severe coronavirus disease 2019 (COVID‐
19). The impact of smoking on COVID‐19 severity has been previously reported in several …

Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …

Background and aims 2019-coronavirus disease (COVID-19) is causing insurmountable
psychosocial impact on the whole mankind. Marginalized community, particularly those with …

While clinical characteristics exhibit that susceptibility to COVID-19 infection is equally likely
between males and females, clinical outcomes show that males experience both a higher …

In December 2019, a novel severe acute respiratory syndrome (SARS) from a new
coronavirus (SARS-CoV-2) was recognized in the city of Wuhan, China. Rapidly, it became …

Introduction Progression of COVID-19 to severe disease and death is insufficiently
understood. Objective Summarize the prevalence of risk factors and adverse outcomes and …

COVID-19 mortality is strongly associated with the development of severe pneumonia and
acute respiratory distress syndrome with the worst outcome resulting in cytokine release …

Background There is uncertainty about the associations of angiotensive enzyme (ACE)
inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. We studied …

Background In the context of the COVID-19 worldwide pandemic, an up-to-date review of
current challenges in addictions is necessary. While large scale disasters may have an …